Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru
Dr Reddy's Laboratories Thursday announced it had entered a co-development and commercialisation agreement with Denmark-based Rheoscience
A/S for the joint development of a drug to treat diabetes. //
Under the pact, Rheoscience
will fund all costs associated with the Phase-III clinical trial...